News
According to TipRanks.com, Richter is a 4-star analyst with an average return of 8.8% and a 42.9% success rate. Richter covers the Healthcare sector, focusing on stocks such as Ultragenyx ...
The U.S. health secretary ordered an end to new mRNA development efforts just after UTMB published new research showing its ...
1d
Barchart on MSNModerna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?With vaccine revenue crumbling and layoffs in full swing, is Moderna’s slimmed-down strategy a smart move or a red flag for ...
The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to create new mRNA vaccines. Experts say this could potentially impact mRNA ...
In a report released yesterday, Cory Kasimov from Evercore ISI maintained a Hold rating on Moderna, with a price target of $32.00. The company’s shares closed yesterday at $27.64. Take advantage of ...
3d
Asianet Newsable on MSNModerna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZenecaThe U.S. health department is canceling or scaling back 22 BARDA-backed mRNA projects worth nearly $500 million, shifting ...
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 7.1% in the afternoon session after the company trimmed the upper ...
A tremendous step backward, the politicization of science, and RFK Jr., who has been a lifelong anti-vaccine propagandist and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results